Drug Database
Back to search

United States· US:73076-509_5b1af203-c2ee-ba2a-e063-6394a90af776

HOMWIS Antifungal Cream

A medicinal product containing eucalyptus globulus leaf oil, registered in United States by Shenzhen Ishan Technology Co., Ltd.

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHOMWIS Antifungal CreamATC—REGISTER NO.US:73076-509_5b1af203…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eucalyptus globulus leaf oilAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
EUCALYPTUS GLOBULUS LEAF OIL
Manufacturer
Shenzhen Ishan Technology Co., Ltd
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    73076-509-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Eucalyptus globulus leaf oil in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eucalyptus globulus leaf oil products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Arzneibad Erkältung Mit Eucalyptus Ab, Arzneibad Eucalyptus
  • United Kingdom (Northern Ireland) · Eucalyptus Oil Bp L.C.M.
  • Poland · Bronchosol Maxipuren

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad9944d8-364f-4ce9-a4a4-eaa5a9832c9e
GET /v1/drugs/ad9944d8-364f-4ce9-a4a4-eaa5a9832c9e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TOPICAL",
  "source": "ndc",
  "strength": "2",
  "substance": "EUCALYPTUS GLOBULUS LEAF OIL",
  "productndc": "73076-509",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "g/100g",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}
API referenceMCP serverPlans

See everything about eucalyptus globulus leaf oil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console